Intramedullary Nailing Versus Plate Fixation of Ankle Fractures. A Prospective, Randomized Controlled Trial.

July 11, 2023 updated by: Elisabeth Ellingsen Husebye, Oslo University Hospital

Intramedullary Nailing Versus Plate Fixation of Ankle Fractures.

The purpose of this study is to make a survey of functional outcome, radiological outcome and complication rate after intramedullary nailing (IMN) and plate fixation of Weber B ankle fractures in elderly patients, and contribute in choosing the best surgical method for these ankle fractures.

Study Overview

Detailed Description

Open reduction and internal fixation (ORIF) is the gold standard treatment for unstable Weber B fractures, using compression screws and a neutralization plate. In the elderly, pre-existing co-morbidities, osteoporosis and poor skin conditions may give a high complication rate, including wound complications, symptomatic hardware and hardware failure. Due to concerns with complications related to ORIF, the technique with intramedullary fixation has been introduced. This method may simplify the management when poor skin conditions and osteoporotic bone, and has the potential to reduce the risk of soft tissue and hardware complications. Previous studies have showed that intramedullary fixation is probably the best choice for treating unstable ankle fractures in elderly patients, but more studies are needed to conclude the superiority to standard plate fixation.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0450
        • Oslo University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Acute unstable Weber B fracture (unimalleolar, bimalleolar or trimalleolar fractures).
  • Operable with both methods of surgery within 3 weeks after injury.
  • Men and women ≥ 60 yoa.

Exclusion Criteria:

  • Prior injury or pathology with reduced ankle function.
  • Other acute foot/ankle/leg injury that will affect ankle function.
  • Fracture of the posterior malleolus that need fixation.
  • Injury / pathology that may affect rehabilitation.
  • Open fracture.
  • Inoperable patient.
  • Dementia (MMSE score ≤ 24 points), reduced competent to consent, not able to express himself/herself in Norwegian or English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Plate
Compression screws and neutralization plate.
Open reduction and internal fixation with screws and plate
Experimental: Intramedullary nail
Acumed Fibular Rod System
intramedullary nailing of fibula

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
American Orthopaedic Foot and Ankle Society (AOFAS) score
Time Frame: 5 years
Functional outcome as assessed by AOFAS score (0-100)
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infection
Time Frame: 3 months
Number of patients with wound infection or deep infection
3 months
Delayed wound healing
Time Frame: 3 months
Number of patients with delayed wound healing
3 months
Manchester-Oxford Foot questionnaire (MOxFQ)
Time Frame: 5 years
Patient reported outcome as assessed by MOxFQ (0-100)
5 years
Olerud and Molander Score (OMS)
Time Frame: 5 years
Patient reported outcome as assessed by OMS (0-100)
5 years
EuroQol-5d (Eq-5d)
Time Frame: 5 years
Patient reported quality of life as assessed by Eq-5d index score
5 years
Visual analogue scale (VAS)
Time Frame: 5 years
VAS scores for pain during rest (0-10), during walking (0-10), at night (0-10), and during daily activities (0-10), where 10 is best
5 years
Fracture reduction as assessed by CT scans
Time Frame: 3 months
Number of patients with good, fair or poor fracture reduction
3 months
Malunion as assessed by CT scans
Time Frame: 5 years
Number of patients with malunion
5 years
Nonunion as assessed by CT scans
Time Frame: 5 years
Number of patients with nonunion
5 years
Osteoarthritis as assessed by CT scans
Time Frame: 5 years
Number of patients with osteoarthritis assessed according to the criteria by McLennan et al
5 years
Other complications
Time Frame: 5 years
Number of patients with other complications (e.g. hardware complications, tromboemolism, neurologic complications, peroneus tendon irritation)
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Elisabeth E Husebye, MD, PhD, Oslo University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

June 1, 2021

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

March 21, 2017

First Submitted That Met QC Criteria

December 13, 2017

First Posted (Actual)

December 19, 2017

Study Record Updates

Last Update Posted (Actual)

July 13, 2023

Last Update Submitted That Met QC Criteria

July 11, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2016/137 (REK)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Fractures

Clinical Trials on Compression screws and neutralization plate

3
Subscribe